Oct. 14 at 1:54 PM
Change in share price of all commercial-stage oncology focused bios with market caps north of
$300MM since last weeks close (using share prices this morning as of 9:40 AM).
The XBI is off 2% where most in this peer group are off much more.
$ZYME is clearly the biggest winner the last 5 trading days
$ONC $GERN $NVCR SNDX &
$AUTL are off the most in the peer group
For information purposes only. This is not investment advice.